RNCOS

China to be the Second Largest IVD Market by 2017

Press Release   •   Feb 27, 2013 14:23 IST

According to a new report by RNCOS, “In-Vitro Diagnostics Market Analysis to 2017”, in 2012, the US led the global IVD market with around 41% share. It was followed by Japan and Germany, which stood at the second and the third position, respectively. The emerging markets of China, India, Mexico and Brazil are however, growing much faster than the developed ones. They are likely to experience a double-digit growth rate in the coming years. Moreover, China is slated to overtake Japan as the second biggest IVD market by 2017.

Our study reveals that the government in emerging economy of China is spending heavily on the construction and up-gradation of its healthcare infrastructure. The report studies the changes that are expected to be spurred due to these developments, highlighting the areas that will provide maximum opportunities for investment and growth.

Like China, other key IVD markets have also been analyzed in detail which will give the reader a detailed understanding of the market dynamics in the region. Each region’s current and future outlook to 2017 has been discussed.  Further, each market has been broken down into eight distinct clinical segmentations and their current and future outlook to 2017 has been analyzed to provide a thorough opportunity assessment.

Besides, the report has delved into the business dynamics of the major players of the market. To provide a thorough understanding of the company’s business model, company’s current and historical financials have been analyzed. Moreover, each company’s strengths and weaknesses along with their recent industrial activities have also been assessed. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.

The report provides a thorough research and rational analysis of the current status and expected position of the global IVD market. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM472.htm

Some of our Related Reports are:

- US Telelaparoscopy Opportunity Analysis (http://www.rncos.com/Report/IM469.htm)
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.